Skip to main content

CTL IP Series 2: What is Patent Eligible in the U.S.?

For this second virtual meeting of the IP series, Dr. John D. Lopinski, Partner at Hodgson Russ LLP, will present an overview of patent eligible subject matter and will provide some examples to illustrate issues related to patent eligibility.

 

Dr. John D. Lopinski will be joined by Bill Pegg, Associate Director for IP at CTL.

 

Topics includes:

  • Overview of patent eligible subject matter
  • Challenges in obtaining patent eligibility in Life Sciences (e.g., Diagnostics, Antibodies, etc.)
  • Challenges in obtaining patent eligibility in Physical Sciences (e.g., Electronics, Encryption, Blockchain, Crypto, Software, etc.)

Weill Digital Health Series #3: Securing Financing and the Founders Experience

Investment in the U.S. digital health sector has significantly increased from $7.5B in 2019 to $14.1B in funding in 2020 . With that number in mind, in the last session of the series, we bring together founders and investors to discuss the increased investors’ interest in digital health innovations, the investment opportunities, and the founders’ experience in this sector.

Silicon Catalyst / Cornell University Technology Showcase

Building on their expanding collaboration to support university tech startups, Silicon Catalyst, the Center for Technology Licensing at Cornell University, and the Praxis Center for Venture Development are pleased to...